UHRF1BP1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.375200E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.578300E-02
Normal-vs-Stage2
1.341260E-03
Normal-vs-Stage3
2.985900E-04
Normal-vs-Stage4
2.314200E-01
Stage1-vs-Stage2
9.041600E-01
Stage1-vs-Stage3
1.839430E-01
Stage1-vs-Stage4
7.259400E-01
Stage2-vs-Stage3
1.599840E-03
Stage2-vs-Stage4
9.035800E-01
Stage3-vs-Stage4
1.928640E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.063800E-02
Normal-vs-AfricanAmerican
3.540800E-01
Normal-vs-Asian
7.540000E-01
Caucasian-vs-AfricanAmerican
1.170240E-01
Caucasian-vs-Asian
3.915200E-01
AfricanAmerican-vs-Asian
5.584400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.233700E-02
Normal-vs-Female
1.743930E-02
Male-vs-Female
2.166400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.798400E-02
Normal-vs-Age(41-60Yrs)
9.581700E-02
Normal-vs-Age(61-80Yrs)
8.614500E-04
Normal-vs-Age(81-100Yrs)
5.827600E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.036000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.351200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.595600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.098800E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.903820E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.561600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.652090E-02
Normal-vs-Daily Drinker
7.015000E-04
Normal-vs-Weekly Drinker
3.190000E-02
Normal-vs-Occasional Drinker
4.043300E-03
Normal-vs-Social Drinker
9.031700E-02
Non Drinker-vs-Daily Drinker
9.578100E-02
Non Drinker-vs-Weekly Drinker
5.817200E-01
Non Drinker-vs-Occasional Drinker
4.638000E-01
Non Drinker-vs-Social Drinker
3.988000E-01
Daily Drinker-vs-Weekly Drinker
4.419900E-02
Daily Drinker-vs-Occasional Drinker
1.158360E-02
Daily Drinker-vs-Social Drinker
2.985600E-02
Weekly Drinker-vs-Occasional Drinker
9.438000E-01
Weekly Drinker-vs-Social Drinker
7.850400E-01
Occasional Drinker-vs-Social Drinker
7.967800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.438800E-01
Normal-vs-Grade 2
2.697800E-01
Normal-vs-Grade 3
2.525800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.338200E-01
Grade 1-vs-Grade 3
4.625200E-01
Grade 1-vs-Grade 4
6.438800E-01
Grade 2-vs-Grade 3
2.675400E-01
Grade 2-vs-Grade 4
2.697800E-01
Grade 3-vs-Grade 4
2.525800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.962900E-03
Normal-vs-NonDiabetic
9.599800E-04
Diabetic-vs-NonDiabetic
3.064200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.609200E-04
Normal-vs-NoPancreatitis
9.203300E-04
Pancreatitis-vs-NoPancreatitis
7.162000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.128030E-02
Normal-vs-N1
1.963880E-03
N0-vs-N1
2.219200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.626840E-01
Normal-vs-TP53-NonMutant
1.051010E-01
TP53-Mutant-vs-TP53-NonMutant
8.343000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
